![]() |
市場調查報告書
商品編碼
2069136
臨床營養:全球市場展望至2031年Clinical Nutrition: Global Markets to 2031 |
||||||
全球臨床營養市場預計將從 2026 年的 795 億美元成長到 2031 年底的 1,047 億美元,在 2026 年至 2031 年的預測期內,複合年成長率將達到 5.6%。
預計北美臨床營養市場將從 2026 年的 373 億美元成長到 2030 年底的 493 億美元,在 2026 年至 2031 年的預測期內,複合年成長率將達到 5.7%。
歐洲臨床營養市場預計將從 2026 年的 236 億美元成長到 2030 年底的 307 億美元,在 2026 年至 2031 年的預測期內,複合年成長率將達到 5.4%。
本報告提供全球臨床營養市場的詳細資訊。報告利用2025年數據、2026年估計值、至2031年的複合年成長率(CAGR)預測(預測期:2026-2031年)以及區域臨床營養市場數據,分析了市場趨勢。報告重點關注臨床營養市場的當前和未來市場潛力,並對競爭格局進行了詳細分析。報告涵蓋監管趨勢、市場促進因素、阻礙因素和機遇,並提供了至2031年的市場預測以及主要參與者的市場佔有率數據。
本報告中的市場範圍按營養類型分類:嬰兒營養、經腸營養和腸外營養。此外,也依最終使用者分類:嬰兒、兒童、成人和老年人。
市場按主要區域分類,包括北美、歐洲、亞太、中東和非洲以及南美。報告對各區域內的主要國家進行了詳細分析,包括美國、加拿大、墨西哥、德國、英國、英國、義大利、西班牙、日本、中國、韓國、澳洲和印度。報告提供了市場估算和預測,包括2025年基準年的數據,以及2026年和2031年的預測數據。
本報告的目的如下:
The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.
The North American market for clinical nutrition is expected to grow from $37.3 billion in 2026 and is projected to reach $49.3 billion by the end of 2030, at a CAGR of 5.7% during the forecast period of 2026 to 2031.
The European market for clinical nutrition is expected to grow from $23.6 billion in 2026 and is projected to reach $30.7 billion by the end of 2030, at a CAGR of 5.4% during the forecast period of 2026 to 2031.
This report provides detailed information on the global clinical nutrition market. It analyzes market trends in clinical nutrition using data from 2025, estimates for 2026, projections of compound annual growth rates through 2031 (forecast period 2026-2031), and regional clinical nutrition markets. This report highlights clinical nutrition's current and future market potential and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2031 and the market share for key market companies.
The market scope in this report is segmented by nutrition type into infant nutrition, enteral nutrition, and parenteral nutrition. The market scope in this report is segmented by end users, which includes infants, children, adults, and geriatrics.
The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2025 because of the base year, with forecasts for 2026 and a forecast value for 2031.
The report aims to: